Q: What is Triumeq used for?

Triumeq is used to treat HIV-1 infection .

Q: How does Triumeq work?

Mechanism of Action Triumeq contains three active ingredients: abacavir, dolutegravir, and lamivudine. These medications belong to a class of drugs known as antiretrovirals, which work by interfering with the enzymes HIV needs to replicate within the body. The medication works through two primary mechanisms: Blocking Integration: Dolutegravir is an integrase strand transfer inhibitor (INSTI). It prevents the HIV integrase enzyme from inserting viral DNA into the host cell's DNA, which stops the virus from taking over the cell to make copies of itself. Blocking Replication: Abacavir and lamivudine are nucleoside reverse transcriptase inhibitors (NRTIs). They block the reverse transcriptase enzyme, which the virus uses to convert its RNA into DNA. Without this conversion, the virus cannot reproduce. By combining these actions, Triumeq helps decrease the viral load (the amount of HIV in the blood) and increase the number of CD4 cells, which are white blood cells that help the body fight infection. While Triumeq helps manage HIV and reduces the risk of transmission, it is not a cure for HIV or AIDS.

Q: What are the active ingredients in Triumeq?

The active ingredients in Triumeq are dolutegravir , abacavir , and lamivudine .

Q: What are the side effects of Triumeq?

Common side effects of Triumeq may include: Insomnia Headache Fatigue and others. Always consult with a healthcare professional about potential side effects.

Q: What is the dosage of Triumeq and how do I take it?

How to Take Triumeq Triumeq is typically taken once a day. It can be taken with or without food. To help you remember your dose, try to take it at the same time every day. Administration Instructions Tablets: Swallow the tablet whole. Dispersible Tablets: If you are using the tablets for oral suspension, do not swallow them whole, chew them, or crush them. These tablets must be dispersed in drinking water before being swallowed. It is important to stay under the care of a healthcare provider while taking this medication. Do not skip doses or stop taking the medication without consulting your doctor, as this can make the virus harder to treat or cause it to become resistant to medications. Missed Doses If you miss a dose of Triumeq, take it as soon as you remember. However, if it is almost time for your next scheduled dose, skip the missed dose and continue with your regular dosing schedule. Do not take two doses at the same time to make up for a missed one.

Q: Is Triumeq safe during pregnancy and breastfeeding?

Pregnancy The use of Triumeq during pregnancy requires careful consideration. One of its components, dolutegravir, has been linked to a small increased risk of neural tube defects (serious problems with the brain or spine) when taken at the time of conception or during early pregnancy. Healthcare providers often recommend a pregnancy test before starting Triumeq in people who can become pregnant. If you are pregnant or planning to conceive, it is important to discuss the risks and benefits of continuing or starting Triumeq with your healthcare provider. They may suggest using effective contraception while taking this medication or may monitor the pregnancy more closely. An Antiretroviral Pregnancy Registry exists to track outcomes for children exposed to these medications in the womb. Breastfeeding In the United States and other regions where safe alternative feeding options are available, healthcare providers recommend that individuals with HIV do not breastfeed. This precaution is taken to prevent the transmission of HIV to the infant through breast milk. Furthermore, the active ingredients in Triumeq—abacavir, dolutegravir, and lamivudine—are known to pass into breast milk, and their potential effects on a nursing baby are not well understood.

Q: What forms and strengths does Triumeq come in?

Triumeq is supplied in the following forms for oral use: Film-coated tablets: These tablets are intended to be swallowed whole. Dispersible tablets: These tablets are designed to be dissolved in drinking water to create a suspension before being swallowed.

Q: What is the FDA approval status of Triumeq?

FDA Approval and Indications Triumeq was approved by the U.S. Food and Drug Administration (FDA) as a complete regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection. It is indicated for use in adults and pediatric patients weighing at least 25 kg. A specific formulation, Triumeq PD, is available for pediatric patients weighing at least 10 kg to less than 25 kg. Boxed Warnings The FDA requires a boxed warning for Triumeq due to several serious safety risks: Hypersensitivity Reactions: Serious and sometimes fatal allergic reactions can occur with the abacavir component. Patients must be screened for the HLA-B*5701 allele before starting treatment, as those with this genetic marker are at a higher risk. Hepatitis B Exacerbation: Patients with both HIV-1 and hepatitis B virus (HBV) may experience severe worsening of their hepatitis B if they stop taking Triumeq. Liver function should be closely monitored in these patients. Lactic Acidosis and Liver Problems: There is a risk of lactic acidosis (buildup of acid in the blood) and severe liver enlargement with fatty liver (hepatomegaly with steatosis), which can be life-threatening. Regulatory Requirements Due to the risk of hypersensitivity reactions, the FDA requires that patients receive a Warning Card to carry with them, which describes the symptoms of an allergic reaction. A Medication Guide must also be provided to every patient when the prescription is filled or refilled.

Question 1

What is Triumeq?

Accepted Answer

Triumeq is a combination medication containing three active ingredients: abacavir, dolutegravir, and lamivudine. It is classified as an antiretroviral therapy designed to decrease the amount of virus present in the system.

The components of this therapy work by inhibiting the viral replication cycle at different stages. This combined approach targets specific proteins necessary for the virus to create new copies of itself, thereby supporting the maintenance of the immune system.

Question 2

What is Triumeq used for?

Accepted Answer

Triumeq is used to treat HIV-1 infection.

Question 3

How does Triumeq work?

Accepted Answer

Mechanism of Action

Triumeq contains three active ingredients: abacavir, dolutegravir, and lamivudine. These medications belong to a class of drugs known as antiretrovirals, which work by interfering with the enzymes HIV needs to replicate within the body.

The medication works through two primary mechanisms:

Blocking Integration: Dolutegravir is an integrase strand transfer inhibitor (INSTI). It prevents the HIV integrase enzyme from inserting viral DNA into the host cell's DNA, which stops the virus from taking over the cell to make copies of itself.
Blocking Replication: Abacavir and lamivudine are nucleoside reverse transcriptase inhibitors (NRTIs). They block the reverse transcriptase enzyme, which the virus uses to convert its RNA into DNA. Without this conversion, the virus cannot reproduce.

By combining these actions, Triumeq helps decrease the viral load (the amount of HIV in the blood) and increase the number of CD4 cells, which are white blood cells that help the body fight infection. While Triumeq helps manage HIV and reduces the risk of transmission, it is not a cure for HIV or AIDS.

Question 4

What are the active ingredients in Triumeq?

Accepted Answer

The active ingredients in Triumeq are dolutegravir, abacavir, and lamivudine.

Question 5

What are the side effects of Triumeq?

Accepted Answer

Common side effects of Triumeq may include:

Insomnia
Headache
Fatigue
and others.

Always consult with a healthcare professional about potential side effects.

Question 6

What drug class is Triumeq?

Accepted Answer

Triumeq belongs to the antiretroviral combination drug class.

Question 7

What is the dosage of Triumeq and how do I take it?

Accepted Answer

How to Take Triumeq

Triumeq is typically taken once a day. It can be taken with or without food. To help you remember your dose, try to take it at the same time every day.

Administration Instructions

Tablets: Swallow the tablet whole.
Dispersible Tablets: If you are using the tablets for oral suspension, do not swallow them whole, chew them, or crush them. These tablets must be dispersed in drinking water before being swallowed.

It is important to stay under the care of a healthcare provider while taking this medication. Do not skip doses or stop taking the medication without consulting your doctor, as this can make the virus harder to treat or cause it to become resistant to medications.

Missed Doses

If you miss a dose of Triumeq, take it as soon as you remember. However, if it is almost time for your next scheduled dose, skip the missed dose and continue with your regular dosing schedule. Do not take two doses at the same time to make up for a missed one.

Question 8

Is Triumeq safe during pregnancy and breastfeeding?

Accepted Answer

Pregnancy

The use of Triumeq during pregnancy requires careful consideration. One of its components, dolutegravir, has been linked to a small increased risk of neural tube defects (serious problems with the brain or spine) when taken at the time of conception or during early pregnancy. Healthcare providers often recommend a pregnancy test before starting Triumeq in people who can become pregnant.

If you are pregnant or planning to conceive, it is important to discuss the risks and benefits of continuing or starting Triumeq with your healthcare provider. They may suggest using effective contraception while taking this medication or may monitor the pregnancy more closely. An Antiretroviral Pregnancy Registry exists to track outcomes for children exposed to these medications in the womb.

Breastfeeding

In the United States and other regions where safe alternative feeding options are available, healthcare providers recommend that individuals with HIV do not breastfeed. This precaution is taken to prevent the transmission of HIV to the infant through breast milk. Furthermore, the active ingredients in Triumeq—abacavir, dolutegravir, and lamivudine—are known to pass into breast milk, and their potential effects on a nursing baby are not well understood.

Question 9

What forms and strengths does Triumeq come in?

Accepted Answer

Triumeq is supplied in the following forms for oral use:

Film-coated tablets: These tablets are intended to be swallowed whole.
Dispersible tablets: These tablets are designed to be dissolved in drinking water to create a suspension before being swallowed.

Question 10

What is the FDA approval status of Triumeq?

Accepted Answer

FDA Approval and Indications

Triumeq was approved by the U.S. Food and Drug Administration (FDA) as a complete regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection. It is indicated for use in adults and pediatric patients weighing at least 25 kg. A specific formulation, Triumeq PD, is available for pediatric patients weighing at least 10 kg to less than 25 kg.

Boxed Warnings

The FDA requires a boxed warning for Triumeq due to several serious safety risks:

Hypersensitivity Reactions: Serious and sometimes fatal allergic reactions can occur with the abacavir component. Patients must be screened for the HLA-B*5701 allele before starting treatment, as those with this genetic marker are at a higher risk.
Hepatitis B Exacerbation: Patients with both HIV-1 and hepatitis B virus (HBV) may experience severe worsening of their hepatitis B if they stop taking Triumeq. Liver function should be closely monitored in these patients.
Lactic Acidosis and Liver Problems: There is a risk of lactic acidosis (buildup of acid in the blood) and severe liver enlargement with fatty liver (hepatomegaly with steatosis), which can be life-threatening.

Regulatory Requirements

Due to the risk of hypersensitivity reactions, the FDA requires that patients receive a Warning Card to carry with them, which describes the symptoms of an allergic reaction. A Medication Guide must also be provided to every patient when the prescription is filled or refilled.

Question 11

What should I know about Triumeq and cost?

Accepted Answer

Insurance Coverage

Triumeq is generally covered by most private insurance plans, Medicare Part D, and Medicaid. However, the amount you pay out-of-pocket depends on your plan's specific benefits, such as deductibles and co-pays. Some plans may require prior authorization from a healthcare provider before they will cover the medication.

Generic Options

Generic versions of the abacavir, dolutegravir, and lamivudine combination are available. Generic drugs are usually more affordable than brand-name medications while providing the same therapeutic benefits. Availability may vary by pharmacy and insurance formulary.

Financial Assistance Programs

If you are concerned about the cost of Triumeq, there are several options that may help reduce the price:

Co-pay Cards: The manufacturer may offer savings cards for patients with commercial insurance to help lower monthly out-of-pocket costs.
Patient Assistance: Programs are often available for individuals who are uninsured or underinsured and meet certain income criteria. These programs may provide the medication at little or no cost.

You can speak with your healthcare provider or pharmacist to learn more about these programs and how to apply for financial support.

Triumeq

📋Overview

How It Works

Uses

Active Ingredients

Common Side Effects

Warnings & Precautions

Dosage

Pregnancy & Breastfeeding

Frequently Asked Questions

📚References

Found an Error?

Find Discounts for Triumeq

Hospitals.net Disclosure